Smart Alert System for Hospital Care

Recruiting at 1 trial location

Overseen By Ernestine Smoot, MAEd

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: David T Huang

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

3000 Participants Needed

Trial Summary

What is the purpose of this trial?

Alerts related to outlier clinician behavior are generated in real-time by an intelligent system continuously scraping EHR (electronic health record) data. These alerts are passed to the bedside and their potential impact on bedside clinical behavior is evaluated.

Research Team

David Huang, MD

Principal Investigator

University of Pittsburgh

Eligibility Criteria

This trial is for critically ill patients being transferred to a healthcare facility. Specific eligibility criteria are not provided, so it's unclear who exactly can participate.

Inclusion Criteria

All patients in the Presbyterian and Montefiore ICUs

Exclusion Criteria

Not applicable.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Alert Evaluation

Real-time evaluation of outlier alerts generated by an AI model from EHR data, reviewed by ICU clinicians for clinical relevance.

Up to 90 days

Daily reviews

Follow-up

Participants are monitored for safety and effectiveness after alert interventions

Up to 90 days

Study Completion

Evaluation of alert system performance and clinical outcomes over the study period

An average of 2 years

Treatment Details

Interventions

• Revealed Alerts
• Unrevealed Alerts

Trial Overview The study tests the effect of real-time alerts on clinician behavior at the bedside. These alerts come from an intelligent system monitoring electronic health records and indicate unusual clinician actions.

Participant Groups

Group I: Revealed Alerts Experimental Treatment 1 Intervention

Group II: Unrevealed Alerts Active Control 1 Intervention

Who Is Running the Clinical Trial?

David T Huang

Lead Sponsor

Trials

1

Recruited

4,600+

National Institute for Biomedical Imaging and Bioengineering (NIBIB)

Collaborator

Trials

102

Recruited

21,600+